References
- Dietert, R. R., Dietert, J. M. 2007. Early-life immune insult and developmental immunotoxicity (DIT)-associated diseases: Potential of herbal- and fungal-derived medicinals. Curr. Med. Chem. 14:1075–1085.
- Dietert, R. R., Etzel, R. A., Chen, D., Halonen, M., Holladay, S. D., Jarabek, A. M., Landreth, K., Peden, D. B., Pinkerton, K., Smialowicz, R. J., Zoetis, T. 2000. Workshop to identify critical windows of exposure for children’s health: Immune and respiratory systems work group summary. Environ. Health Perspect. 108(S3):483–490.
- Food Quality Protection Act. 1996. Title 7 United States Code at Section 1261, as amended.
- Holladay, S. D., Smialowicz, R. J. 2000. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environ. Health Perspect. 108(S3):463–473.
- Holsapple, M. P. 2003. Developmental immunotoxicity testing: A review. Toxicology 185:193–203.
- Holsapple, M. P., Burns-Naas. L. A., Hastings, K. L., Ladics, G. S., Lavin, A. L., Makris, S. L., Yang, Y., Luster, M. I. 2005. A proposed testing framework for developmental immunotoxicology (DIT). Toxicol. Sci. 83:18–24.
- Holsapple, M. P., Paustenbach, D. J., Charnley, G., West, L. J., Luster, M. I., Dietert, R. R., Burns-Naas, L. A. 2004. Symposium summary: Children’s health risk—what’s so special about the developing immune system? Toxicol. Appl. Pharmacol. 199:61–70.
- ILSI Risk Science Institute. 1992. Similarities and differences bet ween children and adults. Institute of Life Sciences, Washington, DC.
- ILSI Risk Science Institute. 1996. Research needs on age-related differences in susceptibility to chemical toxicants. Report of an ILSI Risk Science Institute working group. Institute of Life Sciences, Washington, DC.
- Kavlock, R. J., Daston, G. P., DeRosa, C., Fenner-Crisp, P., Gray, L. E., Kaattari, S., Lucier, G., Luster, M., Mac, M. J., Maczka, C., Miller, R., Moore, J., Rolland, R., Scott, G., Sheehan, D. M., Sinks, T., Tilson, H. A. 1996. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 104(S4):715–740.
- Kimmel, C. A., Collman, G. W., Fields, N., Eskenazi, B. 2005. Lessons learned for the National Children’s Study from the National Institute of Environmental Health Sciences/U.S. Environmental Protection Agency Centers for Children’s Environmental Health and Disease Prevention Research. Environ. Health Perspect. 113:1414–1418.
- Ladics, G. S., Chapin, R. E., Hastings, K. L., Holsapple, M. P., Makris, S. L., Sheets, L. P., Woolhiser, M. R., Burns-Naas, L. A. 2005. Developmental toxicology evaluations - Issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicol. Sci. 88:24–29.
- Luebke, R. W., Chen, D., Dietert, R., Yang, Y., King, M., Luster, M. 2006. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ. Health 9:1–26.
- Luster, M. I., Dean, J. H., Germolec, D. R. 2003. Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 111:579–583.
- Makris, S. L., Bellinger, D., Dietert, R. R., Holladay, S. D., Gogal, R. M. J., Kobzik, L., Fedulov, A., Lim, R., Yang, Y., Rooney, A. A. Curr. Issues Develop. Immunotox. (Submitted).
- National Research Council. 1993. Pesticides in the Diets of Infants and Children. Washington, DC: National Academy Press.
- President Clinton. 1997. Protection of Children from Environmental Health Risks and Safety Risks, Executive Order 13045. Fed. Reg. 51:19883–19888.
- Safe Drinking Water Act. 1996. Title 42 United States Code at Section 300f, as amended.
- Selevan, S. G., Kimmel, C. A., Mendola, P. 2000. Identifying critical windows of exposure for children’s health. Environ. Health Perspect. 108(S3):451–455.
- U.S. EPA. 2002. A review of the reference dose and reference concentration processes. Risk Assessment Forum, Washington, DC. EPA/630/P-02/002F. http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=55365.
- U.S. FDA. 2002. Guidance for Industry: Immunotoxicity Evaluation of Investigational New Drugs. Center for Drug Evaluation and Research, Rockville, MD. http://www.fda.gov/cder/guidance/4945fnl.pdf.
- U.S. FDA. 2006. Guidance for Industry: Non-clinical Safety Evaluation of Pediatric Drug Products. Center for Drug Evaluation and Research, Rockville, MD. http://www.fda.gov/cder/guidance/4945fnl.pdf.